Gabapentin Market in Southeast Asia - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Gabapentin Market in Southeast Asia - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Gabapentin Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Southeast Asia Gabapentin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats

2 COVID-19 Impact: Southeast Asia Gabapentin Overall Market Size
2.1 Southeast Asia Gabapentin Market Size: 2020 VS 2026
2.2 Southeast Asia Gabapentin Revenue, Prospects & Forecasts: 2015-2026
2.3 Southeast Asia Gabapentin Sales (Consumption): 2015-2026

3 Company Landscape
3.1 Top Gabapentin Players in Southeast Asia (including Foreign and Local Companies)
3.2 Top Southeast Asia Gabapentin Companies Ranked by Revenue
3.3 Southeast Asia Gabapentin Revenue by Companies (including Foreign and Local Companies)
3.4 Southeast Asia Gabapentin Sales by Companies (including Foreign and Local Companies)
3.5 Southeast Asia Gabapentin Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Gabapentin Companies in Southeast Asia, by Revenue in 2019
3.7 Southeast Asia Manufacturers Gabapentin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gabapentin Players in Southeast Asia
3.8.1 List of Southeast Asia Tier 1 Gabapentin Companies
3.8.2 List of Southeast Asia Tier 2 and Tier 3 Gabapentin Companies

4 Sights by Product
4.1 Overview
4.1.1 By Type - Southeast Asia Gabapentin Market Size Markets, 2020 & 2026
4.1.2 Capsule
4.1.3 Tablet
4.2 By Type - Southeast Asia Gabapentin Revenue & Forecasts
4.2.1 By Type - Southeast Asia Gabapentin Revenue, 2015-2020
4.2.2 By Type - Southeast Asia Gabapentin Revenue, 2021-2026
4.2.3 By Type - Southeast Asia Gabapentin Revenue Market Share, 2015-2026
4.3 By Type - Southeast Asia Gabapentin Sales & Forecasts
4.3.1 By Type - Southeast Asia Gabapentin Sales, 2015-2020
4.3.2 By Type - Southeast Asia Gabapentin Sales, 2021-2026
4.3.3 By Type - Southeast Asia Gabapentin Sales Market Share, 2015-2026
4.4 By Type - Southeast Asia Gabapentin Price (Manufacturers Selling Prices), 2015-2026
5 Sights by Application
5.1 Overview
5.1.1 By Application - Southeast Asia Gabapentin Market Size, 2020 & 2026
5.1.2 Epilepsy
5.1.3 Neuropathic Pain
5.1.4 Restless Legs Syndrome
5.1.5 Others
5.2 By Application - Southeast Asia Gabapentin Revenue & Forecasts
5.2.1 By Application - Southeast Asia Gabapentin Revenue, 2015-2020
5.2.2 By Application - Southeast Asia Gabapentin Revenue, 2021-2026
5.2.3 By Application - Southeast Asia Gabapentin Revenue Market Share, 2015-2026
5.3 By Application - Southeast Asia Gabapentin Sales & Forecasts
5.3.1 By Application - Southeast Asia Gabapentin Sales, 2015-2020
5.3.2 By Application - Southeast Asia Gabapentin Sales, 2021-2026
5.3.3 By Application - Southeast Asia Gabapentin Sales Market Share, 2015-2026
5.4 By Application - Southeast Asia Gabapentin Price (Manufacturers Selling Prices), 2015-2026
6 Manufacturers & Brands Profiles
6.1 Pfizer
6.1.1 Pfizer Corporate Summary
6.1.2 Pfizer Business Overview
6.1.3 Pfizer Gabapentin Major Product Offerings
6.1.4 Pfizer Sales and Revenue in Southeast Asia (2015-2020)
6.1.5 Pfizer Key News
6.2 Assertio Therapeutics
6.2.1 Assertio Therapeutics Corporate Summary
6.2.2 Assertio Therapeutics Business Overview
6.2.3 Assertio Therapeutics Gabapentin Major Product Offerings
6.2.4 Assertio Therapeutics Sales and Revenue in Southeast Asia (2015-2020)
6.2.5 Assertio Therapeutics Key News
6.3 TEVA
6.3.1 TEVA Corporate Summary
6.3.2 TEVA Business Overview
6.3.3 TEVA Gabapentin Major Product Offerings
6.3.4 TEVA Sales and Revenue in Southeast Asia (2015-2020)
6.3.5 TEVA Key News
6.4 Mylan
6.4.1 Mylan Corporate Summary
6.4.2 Mylan Business Overview
6.4.3 Mylan Gabapentin Major Product Offerings
6.4.4 Mylan Sales and Revenue in Southeast Asia (2015-2020)
6.4.5 Mylan Key News
6.5 Arbor Pharma
6.5.1 Arbor Pharma Corporate Summary
6.5.2 Arbor Pharma Business Overview
6.5.3 Arbor Pharma Gabapentin Major Product Offerings
6.5.4 Arbor Pharma Sales and Revenue in Southeast Asia (2015-2020)
6.5.5 Arbor Pharma Key News
6.6 Novartis
6.6.1 Novartis Corporate Summary
6.6.2 Novartis Business Overview
6.6.3 Novartis Gabapentin Major Product Offerings
6.6.4 Novartis Sales and Revenue in Southeast Asia (2015-2020)
6.6.5 Novartis Key News
6.7 Apotex
6.6.1 Apotex Corporate Summary
6.6.2 Apotex Business Overview
6.6.3 Apotex Gabapentin Major Product Offerings
6.4.4 Apotex Sales and Revenue in Southeast Asia (2015-2020)
6.7.5 Apotex Key News
6.8 Sun Pharmaceutical
6.8.1 Sun Pharmaceutical Corporate Summary
6.8.2 Sun Pharmaceutical Business Overview
6.8.3 Sun Pharmaceutical Gabapentin Major Product Offerings
6.8.4 Sun Pharmaceutical Sales and Revenue in Southeast Asia (2015-2020)
6.8.5 Sun Pharmaceutical Key News
6.9 Aurobindo Pharma
6.9.1 Aurobindo Pharma Corporate Summary
6.9.2 Aurobindo Pharma Business Overview
6.9.3 Aurobindo Pharma Gabapentin Major Product Offerings
6.9.4 Aurobindo Pharma Sales and Revenue in Southeast Asia (2015-2020)
6.9.5 Aurobindo Pharma Key News
6.10 Intas
6.10.1 Intas Corporate Summary
6.10.2 Intas Business Overview
6.10.3 Intas Gabapentin Major Product Offerings
6.10.4 Intas Sales and Revenue in Southeast Asia (2015-2020)
6.10.5 Intas Key News
6.11 Amneal
6.11.1 Amneal Corporate Summary
6.11.2 Amneal Gabapentin Business Overview
6.11.3 Amneal Gabapentin Major Product Offerings
6.11.4 Amneal Sales and Revenue in Southeast Asia (2015-2020)
6.11.5 Amneal Key News
6.12 Marksans Pharma
6.12.1 Marksans Pharma Corporate Summary
6.12.2 Marksans Pharma Gabapentin Business Overview
6.12.3 Marksans Pharma Gabapentin Major Product Offerings
6.12.4 Marksans Pharma Sales and Revenue in Southeast Asia (2015-2020)
6.12.5 Marksans Pharma Key News
6.13 Glenmark
6.13.1 Glenmark Corporate Summary
6.13.2 Glenmark Gabapentin Business Overview
6.13.3 Glenmark Gabapentin Major Product Offerings
6.13.4 Glenmark Sales and Revenue in Southeast Asia (2015-2020)
6.13.5 Glenmark Key News
6.14 Alkem
6.14.1 Alkem Corporate Summary
6.14.2 Alkem Gabapentin Business Overview
6.14.3 Alkem Gabapentin Major Product Offerings
6.14.4 Alkem Sales and Revenue in Southeast Asia (2015-2020)
6.14.5 Alkem Key News
6.15 Jiangsu Enhua
6.15.1 Jiangsu Enhua Corporate Summary
6.15.2 Jiangsu Enhua Gabapentin Business Overview
6.15.3 Jiangsu Enhua Gabapentin Major Product Offerings
6.15.4 Jiangsu Enhua Sales and Revenue in Southeast Asia (2015-2020)
6.15.5 Jiangsu Enhua Key News
6.16 Jiangsu Hengrui
6.16.1 Jiangsu Hengrui Corporate Summary
6.16.2 Jiangsu Hengrui Gabapentin Business Overview
6.16.3 Jiangsu Hengrui Gabapentin Major Product Offerings
6.16.4 Jiangsu Hengrui Sales and Revenue in Southeast Asia (2015-2020)
6.16.5 Jiangsu Hengrui Key News
6.17 Sailike
6.17.1 Sailike Corporate Summary
6.17.2 Sailike Gabapentin Business Overview
6.17.3 Sailike Gabapentin Major Product Offerings
6.17.4 Sailike Sales and Revenue in Southeast Asia (2015-2020)
6.17.5 Sailike Key News

7 Gabapentin Production Capacity, Export and Import Analysis
7.1 Gabapentin Production Capacity and Value in Southeast Asia, Situation Analysis and Prediction, 2015-2026
7.1.1 Southeast Asia Gabapentin Production Capacity, 2015-2026
7.1.2 Southeast Asia Gabapentin Production 2015-2026
7.1.3 Southeast Asia Gabapentin Production Value 2015-2026
7.2 Key Local Gabapentin Manufacturers in Southeast Asia
7.2.1 Southeast Asia Key Local Gabapentin Manufacturers Production Capacity
7.2.2 Southeast Asia Key Local Gabapentin Manufacturers Production
7.2.3 Southeast Asia Key Local Gabapentin Manufacturers Production Value
7.2.4 The Proportion of Gabapentin Production Sold in Southeast Asia and Sold Other Than Southeast Asia by Manufacturers
7.3 Gabapentin Export and Import in Southeast Asia
7.3.1 Southeast Asia Gabapentin Export Market
7.3.2 Southeast Asia Gabapentin Source of Imports

8 COVID-19 Impact: Key Market Trends, Opportunity, Drivers and Restraints
8.1 PESTLE Analysis for Southeast Asia Gabapentin Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 COVID-19 Impact on Gabapentin Supply Chain Analysis
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Gabapentin Distributors and Sales Agents in Southeast Asia

10 Conclusion

11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer

List of Tables
Table 1. Key Players of Gabapentin in Southeast Asia
Table 2. Top Players in Southeast Asia, Ranking by Revenue (2019)
Table 3. Southeast Asia Gabapentin Revenue by Companies, (US$, Mn), 2015-2020
Table 4. Southeast Asia Gabapentin Revenue Share by Companies, 2015-2020
Table 5. Southeast Asia Gabapentin Sales by Companies, (K MT), 2015-2020
Table 6. Southeast Asia Gabapentin Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Gabapentin Price (2015-2020) (USD/MT)
Table 8. Southeast Asia Manufacturers Gabapentin Product Type
Table 9. List of Southeast Asia Tier 1 Gabapentin Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of Southeast Asia Tier 2 and Tier 3 Gabapentin Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Gabapentin Revenue in Southeast Asia (US$, Mn), 2015-2020
Table 12. By Type - Gabapentin Revenue in Southeast Asia (US$, Mn), 2021-2026
Table 13. By Type - Gabapentin Sales in Southeast Asia (K MT), 2015-2020
Table 14. By Type - Gabapentin Sales in Southeast Asia (K MT), 2021-2026
Table 15. By Application - Gabapentin Revenue in Southeast Asia, (US$, Mn), 2015-2020
Table 16. By Application - Gabapentin Revenue in Southeast Asia, (US$, Mn), 2021-2026
Table 17. By Application - Gabapentin Sales in Southeast Asia, (K MT), 2015-2020
Table 18. By Application - Gabapentin Sales in Southeast Asia, (K MT), 2021-2026
Table 19. Pfizer Corporate Summary
Table 20. Pfizer Gabapentin Product Offerings
Table 21. Pfizer Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 22. Assertio Therapeutics Corporate Summary
Table 23. Assertio Therapeutics Gabapentin Product Offerings
Table 24. Assertio Therapeutics Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 25. TEVA Corporate Summary
Table 26. TEVA Gabapentin Product Offerings
Table 27. TEVA Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 28. Mylan Corporate Summary
Table 29. Mylan Gabapentin Product Offerings
Table 30. Mylan Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 31. Arbor Pharma Corporate Summary
Table 32. Arbor Pharma Gabapentin Product Offerings
Table 33. Arbor Pharma Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 34. Novartis Corporate Summary
Table 35. Novartis Gabapentin Product Offerings
Table 36. Novartis Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 37. Apotex Corporate Summary
Table 38. Apotex Gabapentin Product Offerings
Table 39. Apotex Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 40. Sun Pharmaceutical Corporate Summary
Table 41. Sun Pharmaceutical Gabapentin Product Offerings
Table 42. Sun Pharmaceutical Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 43. Aurobindo Pharma Corporate Summary
Table 44. Aurobindo Pharma Gabapentin Product Offerings
Table 45. Aurobindo Pharma Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 46. Intas Corporate Summary
Table 47. Intas Gabapentin Product Offerings
Table 48. Intas Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 49. Amneal Corporate Summary
Table 50. Amneal Gabapentin Product Offerings
Table 51. Amneal Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 52. Marksans Pharma Corporate Summary
Table 53. Marksans Pharma Gabapentin Product Offerings
Table 54. Marksans Pharma Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 55. Glenmark Corporate Summary
Table 56. Glenmark Gabapentin Product Offerings
Table 57. Glenmark Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 58. Alkem Corporate Summary
Table 59. Alkem Gabapentin Product Offerings
Table 60. Alkem Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 61. Jiangsu Enhua Corporate Summary
Table 62. Jiangsu Enhua Gabapentin Product Offerings
Table 63. Jiangsu Enhua Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 64. Jiangsu Hengrui Corporate Summary
Table 65. Jiangsu Hengrui Gabapentin Product Offerings
Table 66. Jiangsu Hengrui Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 67. Sailike Corporate Summary
Table 68. Sailike Gabapentin Product Offerings
Table 69. Sailike Gabapentin Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 70. Gabapentin Production Capacity (K MT) of Local Manufacturers in Southeast Asia, 2015-2020
Table 71. Gabapentin Production (K MT) of Local Manufacturers in Southeast Asia, 2015-2020
Table 72. Southeast Asia Gabapentin Production Market Share of Local Manufacturers, 2015-2020
Table 73. Gabapentin Production Value (US$, Mn) of Local Manufacturers in Southeast Asia, 2015-2020
Table 74. Southeast Asia Gabapentin Production Value Market Share of Local Manufacturers, 2015-2020
Table 75. The Percentage of Gabapentin Production Sold in Southeast Asia and Sold Other Than Southeast Asia by Manufacturers
Table 76. The Percentage of Gabapentin Production Sold in Southeast Asia and Sold Other Than Southeast Asia by Manufacturers
Table 77. Dangeguojia Gabapentin Sales (Consumption), Production, Export and Import, 2015-2020
Table 78. Raw Materials and Suppliers
Table 79. Gabapentin Downstream Clients in Southeast Asia
Table 80. Gabapentin Distributors and Sales Agents in Southeast Asia
List of Figures
Figure 1. Gabapentin Segment by Type
Figure 2. Gabapentin Segment by Application
Figure 3. Dangeguojia Gabapentin Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Gabapentin Market Size in Southeast Asia, (US$, Mn) & (K MT): 2020 VS 2026
Figure 6. Southeast Asia Gabapentin Revenue, 2015-2026 (US$, Mn)
Figure 7. Gabapentin Sales in Southeast Asia: 2015-2026 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Gabapentin Revenue in 2019
Figure 9. By Type - Southeast Asia Gabapentin Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - Southeast Asia Gabapentin Market Share, 2015-2020
Figure 11. By Type - Southeast Asia Gabapentin Market Share, 2020-2026
Figure 12. By Type - Southeast Asia Gabapentin Price (USD/MT), 2015-2026
Figure 13. By Application - Gabapentin Revenue in Southeast Asia (US$, Mn), 2020 & 2026
Figure 14. By Application - Southeast Asia Gabapentin Market Share, 2015-2020
Figure 15. By Application - Southeast Asia Gabapentin Market Share, 2020-2026
Figure 16. By Application -Southeast Asia Gabapentin Price (USD/MT), 2015-2026
Figure 17. Southeast Asia Gabapentin Production Capacity (K MT), 2015-2026
Figure 18. Southeast Asia Gabapentin Actual Output (K MT), 2015-2026
Figure 19. Southeast Asia Gabapentin Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of Southeast Asia Gabapentin Export Destination, 2019
Figure 21. The Source of Imports of Southeast Asia Gabapentin, 2019
Figure 22. PEST Analysis for Southeast Asia Gabapentin Market in 2020
Figure 23. Gabapentin Market Opportunities & Trends in Southeast Asia
Figure 24. Gabapentin Market Drivers in Southeast Asia
Figure 25. Gabapentin Market Restraints in Southeast Asia
Figure 26. Gabapentin Industry Value Chain

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Restless Legs Syndrome Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112

According to our LPI (LP Information) latest study, the global Restless Legs Syndrome market size was valued at US$ million in 2023. With growing demand in downstream market, the Restless Legs Syndrome is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Restless Legs Syndrome market. Restless Legs Syndrome are expected to show stable growth in the future market. However, product di......

Global Autism Spectrum Disorder Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 110

Report Overview: Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities. Diagnosing autism spectrum disorder (ASD) can be difficult, since there is no medical test, like a blood test, to diagnose the disorders. Doctors look at the child's behavior and development to make a diagnosis. Our report studies the market......

Global Epilepsy Therapeutics Market Research Report 2023

Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 86

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Epilepsy Therapeutics market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Abbott Laboratories - Cephalon - Novartis - Pfizer - Johnson & Johnson - GlaxoSmithKline - Sanofi - Sunovion Pharmaceuticals......

Global Autism Spectrum Disorder Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Autism Spectrum Disorder market: According to our latest research, the global Autism Spectrum Disorder market looks promising in the next 5 years. As of 2022, the global Autism Spectrum Disorder market was estimated at USD 464.19 million, and it's anticipated to reach USD 700.88 million in 2028, with a CAGR of 7.11% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of ......

Global Autism Spectrum Disorder Market Status and Outlook 2023-2028

Published: 24-Nov-2023        Price: US 3160 Onwards        Pages: 109

Autism spectrum disorder (ASD) is a complex developmental condition that involves persistent challenges in social interaction, speech and nonverbal communication, and restricted/repetitive behaviors. The effects of ASD and the severity of symptoms are different in each person. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segmen......

Global Epilepsy Therapeutics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Epilepsy Therapeutics market: According to our latest research, the global Epilepsy Therapeutics market looks promising in the next 5 years. As of 2022, the global Epilepsy Therapeutics market was estimated at USD 11157.84 million, and it's anticipated to reach USD 13510.46 million in 2028, with a CAGR of 3.24% during the forecast years. Epilepsy is a group of neurological disorders characterized by seizures. The onset of a seizure can range from a b......

Global Gabapentin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 12-Oct-2023        Price: US 3380 Onwards        Pages: 98

Market Overview of Global Gabapentin market: According to our latest research, the global Gabapentin market looks promising in the next 5 years. As of 2022, the global Gabapentin market was estimated at USD 1627.13 million, and it's anticipated to reach USD 1844.92 million in 2028, with a CAGR of 2.12% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Gabapentin market, with a sys......

2023-2031 Report on Global Autism Spectrum Disorder Market by Player, Region, Type, Application and Sales Channel

Published: 09-Oct-2023        Price: US 2500 Onwards        Pages: 89

This report studies the Autism Spectrum Disorder market, covering market size for segment by type (Center-Based, In-Home, etc.), by application (1-14 Years Old, 15-25 Years Old, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Otsuka, Astrazeneca, Pfizer, Eli Lilly, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Aut......

Global Gabapentin Market Insights, Forecast to 2029

Published: 27-Sep-2023        Price: US 4900 Onwards        Pages: 112

Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain. The global Gabapentin market is projected to grow from US$ 1572.1 million in 2023 to US$ 1749.7 million by 2029, at a Compound Annual Growth Ra......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs